WELLS FARGO & COMPANY/MN
Position in IDXGD — Interpace Biosciences, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in IDXGD
as of Dec 31, 2020
· filed Feb 9, 2021
Position Value
$0
+$0 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXGD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $2,228,724,937 across 35 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,458,431 | $731,198,964 | |
| 2 | DHR |
Danaher Corp /De/
|
2,107,482 | $401,433,168 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,751,220 | $371,171,075 | |
| 4 | NTRA |
Natera, Inc.
|
502,818 | $136,489,944 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
209,092 | $110,074,391 | |
| 6 | LH |
Labcorp Holdings Inc.
|
347,544 | $97,312,320 | |
| 7 | WAT |
Waters Corp /De/
|
168,498 | $63,193,487 | |
| 8 | A |
Agilent Technologies, Inc.
|
462,412 | $61,422,185 |
All Filings in IDXGD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2020-12-31 | — | 25 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | — | 25 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | — | 26 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 26 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||